LON:DNL - Diurnal Group Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: GBX 0
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
GBX 56.70
▼ -0.3 (-0.53%)

This chart shows the closing price for DNL by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Diurnal Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for DNL and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for DNL

Analyst Price Target is GBX 0
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Diurnal Group in the last 3 months. The average price target is GBX 0, with a high forecast of GBX 0 and a low forecast of £100,000. The average price target represents a -100.00% upside from the last price of GBX 56.70.

This chart shows the closing price for DNL for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in Diurnal Group. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/13/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/11/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/10/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/10/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/8/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/6/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/5/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/5/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
2/13/2018Numis SecuritiesReiterated RatingBuyGBX 185
12/18/2017Numis SecuritiesReiterated RatingBuyGBX 185
9/6/2017Numis SecuritiesReiterated RatingBuyGBX 169
6/15/2017Panmure GordonReiterated RatingBuyGBX 178
4/4/2017Numis SecuritiesReiterated RatingBuyGBX 169
3/20/2017Numis SecuritiesLower Price TargetBuyGBX 187 ➝ GBX 169
3/2/2017Numis SecuritiesReiterated RatingBuyGBX 187
1/25/2017Numis SecuritiesReiterated RatingBuyGBX 187
12/21/2016Numis SecuritiesReiterated RatingBuyGBX 187
(Data available from 12/5/2016 forward)

News Sentiment Rating

0.60 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/9/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/8/2021
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/8/2021
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/7/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/6/2021
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
10/6/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/5/2021
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/5/2021

Current Sentiment

  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Diurnal Group logo
Diurnal Group plc operates as a specialty pharma company worldwide. The company develops hormone therapeutics for the treatment of chronic endocrine conditions, including congenital adrenal hyperplasia, adrenal insufficiency, hypogonadism, and hypothyroidism. The company offers Alkindi, a replacement therapy for paediatric adrenal insufficiency in Europe. It also develops Chronocort, which completed Phase III clinical trials targeting congenital adrenal hyperplasia and adrenal insufficiency. The company's early stage pipeline products comprise Native Oral Testosterone, a replacement treatment for patients suffering from hypogonadism; siRNA, a short interfering RNA oligonucleotide therapy for patients suffering from adrenocorticotropin-dependent Cushing's syndrome; and T3 modified, a modified-release preparation of T3 (levothyroxine) hormone for patients suffering from hypothyroidism. Diurnal Group plc was incorporated in 2015 and is headquartered in Cardiff, the United Kingdom.
Read More

Today's Range

Now: GBX 56.70
Low: 56.25
High: 57

50 Day Range

MA: GBX 58.85
Low: 52.50
High: 62

52 Week Range

Now: GBX 56.70
Low: 47
High: 97.98

Volume

109,565 shs

Average Volume

284,604 shs

Market Capitalization

£95.85 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Diurnal Group?

The following Wall Street sell-side analysts have issued reports on Diurnal Group in the last twelve months:
View the latest analyst ratings for DNL.

What is the current price target for Diurnal Group?

0 Wall Street analysts have set twelve-month price targets for Diurnal Group in the last year. has the lowest price target set, forecasting a price of £100,000 for Diurnal Group in the next year.
View the latest price targets for DNL.

What is the current consensus analyst rating for Diurnal Group?

Diurnal Group currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for DNL.

How do I contact Diurnal Group's investor relations team?

Diurnal Group's physical mailing address is Heath Park, CARDIFF, CF14 4UJ, United Kingdom. The company's listed phone number is +44-29-20682069. The official website for Diurnal Group is www.diurnal.co.uk.